Table 4.
2025 health burden for aggregated non-road, on-road and air/rail/marine sectors.
| Non-road | On-road | Air/Rail/Marine | |
|---|---|---|---|
| Premature death | |||
| Krewski et al (2009) & Bell et al (2004) | 3900 (2400–5400) | 6700 (4100–9200) | 2900 (1700–4100) |
| Lepeule et al (2012) & Levy et al (2005) | 11 000 (6000–15 000) | 18 000 (10 000–26 000) | 8500 (5000–12 000) |
| Non-Fatal heart attacks | |||
| Peters et al (2001) | 3200 (780–5600) | 5700 (1400–10 000) | 2100 (520–3700) |
| Pooled estimate of four studies | 350 (130–930) | 620 (230–1700) | 230 (84–610) |
| Cardiovascular hospital admissions | 820 (360–1500) | 1500 (640–2700) | 540 (240–990) |
| Respiratory hospital admissions | 2100 ((590)–4500) | 3600 ((1000)–7500) | 2000 ((550)—4400) |
| Respiratory emergency Department visits | 7400 ((180)–20 000) | 12 000 ((380)–33 000) | 7200 (130–21 000) |
| Acute bronchitis | 4400 ((1000)–9800) | 8000 ((1900)–18 000) | 2900 ((680)—6500) |
| Acute respiratory symptoms | 6 400 000 (3 600 000–9 300 000) | 11 000 000 (6 100 000–15 000 000) | 6 100 000 (3 200 000–9 100 000) |
| Aggravated asthma | 1 900 000 ((1 500 000)–4 500 000) | 3 000 000 ((2 400 000)–7 200 000) | 2 000 000 ((1 700 000)—4 900 000) |
| Upper respiratory symptoms | 80 000 (14 000–140 000) | 140 000 (26 000–260 000) | 53 000 (9500–95 000) |
| Lower respiratory symptoms | 56 000 (21 000–91 000) | 100 000 (39 000–160 000) | 37 000 (14 000–60 000) |
| Lost work days | 410 000 (340 000–470 000) | 730 000 (620 000–840 000) | 270 000 (230 000–310 000) |
| Lost school days | 1 300 000 (460 000–2 900 000) | 2 100 000 (740 000–4 600 000) | 1 400 000 (510 000–3 200 000) |